Cosmos Holdings Inc (COSM)
NASDAQ:COSM
Want to see COSM full AI Analyst Report?
COSM Stock Chart & Stats
$0.52
-$0.04(-5.45%)
At close: 4:00 PM EST
$0.52
-$0.04(-5.45%)
Day’s Range― - ―
52-Week Range$0.28 - $1.32
Previous CloseN/A
Volume59.12K
Average Volume (3M)1.18M
Market Cap
$14.62M
Enterprise Value$30.81M
Total Cash (Recent Filing)$922.62K
Total Debt (Recent Filing)$21.07M
Price to Earnings (P/E)―
Beta2.16
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding37,432,520
10 Day Avg. Volume1,246,475
30 Day Avg. Volume1,183,471
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.82
Price to Sales (P/S)0.23
P/FCF Ratio-1.77
Enterprise Value/Market Cap2.11
Enterprise Value/Revenue0.52
Enterprise Value/Gross Profit4.52
Enterprise Value/Ebitda-2.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.11
Revenue Forecast (FY)$98.60M
Bulls Say, Bears Say
Bulls Say
Revenue & Margin ImprovementSustained revenue recovery and materially higher gross margin reflect improving unit economics and scaling of core distribution and branded product lines. Durable margin expansion increases operating leverage potential, supporting a credible path to profitability as volumes and mix stabilize over coming quarters.
Long-term Manufacturing Contracts & IP PipelineMulti-year manufacturing agreements and advancing proprietary drug-repurposing patents create recurring revenue visibility and potential high-margin manufacturing throughput. These structural assets support predictable revenue, higher gross margins, and optionality from future licensing or specialty drug commercialization.
Distribution Expansion And U.S. Product LaunchesBroader retail and geographic distribution, plus targeted U.S. launches, diversify revenue sources and reduce regional concentration. High-margin branded SKUs and expanded pharmacy/retail channels create durable sales channels that can scale recurring revenue and improve overall margin profile over multiple reporting periods.
Bears Say
Persistent Negative Cash FlowChronic negative operating and free cash flow forces ongoing reliance on external financing or asset monetization, constraining reinvestment and strategic flexibility. Continued cash burn increases risk of dilution or scaled-back growth initiatives if operating cash generation does not turn sustainably positive.
Structural UnprofitabilityLarge operating and net losses indicate the business has not yet achieved operating leverage sufficient to cover overhead. Until profitable operations are sustained, the company will face pressure on capital, credit access, and investor tolerance, slowing strategic execution and increasing funding risk.
Material Equity ErosionSignificant decline in shareholders' equity reduces financial cushion, limits borrowing capacity, and heightens vulnerability to adverse shocks. Even with manageable current debt, diminished equity undermines flexibility for M&A, capex or weathering prolonged losses without dilutive financing or asset sales.
Cosmos Holdings News
COSM FAQ
What was Cosmos Holdings Inc’s price range in the past 12 months?
Cosmos Holdings Inc lowest stock price was $0.28 and its highest was $1.32 in the past 12 months.
What is Cosmos Holdings Inc’s market cap?
Cosmos Holdings Inc’s market cap is $14.62M.
When is Cosmos Holdings Inc’s upcoming earnings report date?
Cosmos Holdings Inc’s upcoming earnings report date is May 20, 2026 which is in 34 days.
How were Cosmos Holdings Inc’s earnings last quarter?
Cosmos Holdings Inc released its earnings results on Apr 15, 2026. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.07 by $0.03.
Is Cosmos Holdings Inc overvalued?
According to Wall Street analysts Cosmos Holdings Inc’s price is currently Overvalued.
Does Cosmos Holdings Inc pay dividends?
Cosmos Holdings Inc does not currently pay dividends.
What is Cosmos Holdings Inc’s EPS estimate?
Cosmos Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cosmos Holdings Inc have?
Cosmos Holdings Inc has 37,432,520 shares outstanding.
What happened to Cosmos Holdings Inc’s price movement after its last earnings report?
Cosmos Holdings Inc reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.07. Following the earnings report the stock price went up 16.766%.
Which hedge fund is a major shareholder of Cosmos Holdings Inc?
Currently, no hedge funds are holding shares in COSM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cosmos Holdings Inc
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Technical Analysis
Ownership Overview
23.67% Insiders
0.82% Mutual Funds
0.10% Other Institutional Investors
75.04% Public Companies and
Individual Investors